[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350067-105":59,"doc-detail-350067-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-nuclear-import-suppresses-androgen-receptor-action-and-overcomes-resistance-in-prostate-cancer","Inhibition of nuclear import suppresses androgen receptor action and overcomes resistance in prostate cancer","","The study examines how inhibiting nuclear import affects androgen receptor (AR) signaling and resistance to enzalutamide in prostate cancer models. Using nuclear import inhibitors (importazole, ivermectin) and KPNB1 (importin β) knockdown, the research evaluates AR localization, AR-dependent transactivation, and measures of viability and apoptosis across wild-type AR, AR-F876L mutant, and AR-V7 splice variant expressing cells. Results show nuclear import blockade suppresses AR activity, redirects AR to the cytoplasm, and enhances enzalutamide-induced apoptosis, overcoming drug resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-nuclear-import-suppresses-androgen-receptor-action-and-overcomes-resistance-in-prostate-cancer/350067/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-nuclear-import-suppresses-androgen-receptor-action-and-overcomes-resistance-in-prostate-cancer/350067.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why do prostate cancers develop resistance to androgen deprivation therapies?","Question",{"text":112,"@type":113},"After an initially effective response, tumors often become resistant due to mechanisms such as AR mutations that enable ligand-independent activation and nuclear translocation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What approach did the study use to inhibit nuclear import?",{"text":117,"@type":113},"The study used nuclear import inhibitors (importazole and ivermectin) and knockdown of KPNB1 (importin β) in prostate cancer cell models.",{"name":119,"@type":110,"acceptedAnswer":120},"How does nuclear import inhibition affect enzalutamide response in AR-F876L or AR-V7 models?",{"text":121,"@type":113},"Nuclear import inhibition suppresses enzalutamide-induced nuclear localization and transactivation of the mutated AR-F876L, reducing viability. For AR-V7, importazole and ivermectin attenuate constitutive AR transcriptional activation, while enzalutamide shows no effect.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350067,1790343802,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Wang et al. BMC Cancer (2026) 26:428 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15792-y](https://doi.org/10.1186/s12885-026-15792-y)  \nRESEARCH Open Access  \nInhibition of nuclear import suppresses androgen receptor action and overcomes resistance in prostate cancer  \nXuan Wang1, Xin Xu1, Shengyun Fang2, Xiaolei Shi3*† andYili Yang1*†  \nAbstract  \nBackground Androgen deprivation and androgen receptor (AR) antagonists are essential treatments for prostate cancers in the clinic. However, after an initially effective response, most tumors become resistant to androgen deprivation therapies. Resistance often arises from AR mutations, resulting in ligand-independent activation and nuclear translocation of AR.  \nMethods This study investigated the effects of nuclear import inhibition on AR signaling and enzalutamide resistance. We utilized nuclear import inhibitors (importazole and ivermectin) and KPNB1 (importin β) knockdown in prostate cancer cell models. We assessed AR subcellular localization, AR-dependent transactivation (transcriptional activity), cell viability and apoptosis in cells expressing wild-type AR, the AR-F876L mutant, or the constitutively active AR splice variant AR-V7 .  \nResults Inhibition of nuclear import suppressed AR-dependent transactivation, increased cytoplasmic AR, and enhanced the action of enzalutamide by promoting the apoptosis of prostate cancer cells. While enzalutamide became an AR agonist in cells harboring the mutated AR (F876L), inhibition of nuclear import inhibited enzalutamideinduced nuclear localization and transactivation of the mutated AR and reduced the viability of AR-F876L-expressing cells. Both importazole and ivermectin attenuated the transcriptional activation induced by a constitutively active AR splice variant (AR-V7), while enzalutamide showed no effect.  \nConclusion Inhibition of nuclear import can overcome enzalutamide resistance and may serve as a novel strategy for prostate cancer treatment.  \nKeywords Nuclear import, Androgen receptor, Prostate cancer, Resistance  \n†Xiaolei Shi and Yili Yang contributed equally to this study.  \n*Correspondence: Xiaolei Shi [neilsxl@foxmail.com](neilsxl@foxmail.com)[ ](neilsxl@foxmail.com)Yili Yang [nathanyang@icgeb.cn](nathanyang@icgeb.cn)  \n1China Regional Research Center, International Centre for Genetic Engineering and Biotechnology, Taizhou 225316, Jiangsu, China 2Center for Biomedical Engineering and Technology, Department of Physiology, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore MD 21201, USA 3Department of Urology, Shanghai Changhai Hospital, 168 Changhai Road, Shanghai 200433, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nWang et al. BMC Cancer (2026) 26:428  \nBackground  \nProstate cancer is one of the most common cancers and the leading cause of cancer death in men worldwide [1]. As ","cbCaigi6USzx2JhT","https://ap.wps.com/l/cbCaigi6USzx2JhT","pdf",2762891,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Background","[{\"question\":\"Why do prostate cancers develop resistance to androgen deprivation therapies?\",\"answer\":\"After an initially effective response, tumors often become resistant due to mechanisms such as AR mutations that enable ligand-independent activation and nuclear translocation.\"},{\"question\":\"What approach did the study use to inhibit nuclear import?\",\"answer\":\"The study used nuclear import inhibitors (importazole and ivermectin) and knockdown of KPNB1 (importin β) in prostate cancer cell models.\"},{\"question\":\"How does nuclear import inhibition affect enzalutamide response in AR-F876L or AR-V7 models?\",\"answer\":\"Nuclear import inhibition suppresses enzalutamide-induced nuclear localization and transactivation of the mutated AR-F876L, reducing viability. For AR-V7, importazole and ivermectin attenuate constitutive AR transcriptional activation, while enzalutamide shows no effect.\"}]","Inhibition of nuclear import suppresses androgen receptor action and overcomes resistance in prostate cancer | PDF",1790086986,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a122968ece73b6ab0599f8b2f74e2b19.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09d9bd38bfd7ecc82de5d286dd1e4e88.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9eea14d9f20b947b081324455b68516.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13b1df52279188551e8860d7714d6376.webp",980,1306]